Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovotech ( (TSE:IOT) ) has shared an announcement.
Innovotech Inc. is expanding its analytical laboratory services by offering an unsecured convertible debenture of $200,000, subject to regulatory approval. The funds will enhance its Keystone Labs division’s capabilities, allowing Innovotech to better serve regulated markets in health product commercialization and pharmaceuticals. This strategic move aims to diversify revenue streams and strengthen Innovotech’s position as a leading contract research organization. The company also announced the addition of Jeff Kelly, who will help establish Innovotech as a trusted provider of analytical services.
More about Innovotech
Innovotech Inc. is a Canadian technology company engaged in specialized laboratory services, biotechnology, and proprietary intellectual property. It operates through several subsidiaries, including Innovotech Labs Corporation, which provides proprietary devices for antimicrobial testing.
Average Trading Volume: 33,018
Technical Sentiment Signal: Buy
Current Market Cap: C$9.8M
For a thorough assessment of IOT stock, go to TipRanks’ Stock Analysis page.